Understanding the benefit of current personalised medicine platforms
Symposium Chairs: B. Jobst (Heidelberg, Germany), E. Quoix (Strasbourg, France)
Aims: The aim of this session is to explore the benefit of personalised medicine in lung cancer and to educate the audience regarding the different technologies that are currently available.